Cranial polyneuropathy as the first manifestation of a severe COVID-19 in a child
Corresponding Author
Aphaia Roussel
Pediatric Hematology-Immunology Department, University Hospital Robert-Debre (APHP), Paris, France
Correspondence
Aphaia Roussel, Pediatric Hematology-Immunology Department, University Hospital Robert Debré (APHP), 48 Bd Sérurier, Cedex 19, 75935 Paris, France.
Email: [email protected]
Search for more papers by this authorDavid Germanaud
Pediatric Neurology Department, University Hospital Robert-Debre (APHP), Paris, France
Search for more papers by this authorYassine Bouchoucha
Pediatric Hematology-Immunology Department, University Hospital Robert-Debre (APHP), Paris, France
Search for more papers by this authorNaïm Ouldali
General Pediatric Department and Infectious Diseases, University Hospital Robert-Debre (APHP), Paris, France
Search for more papers by this authorMeryl Vedrenne-Cloquet
Pediatric Intensive Care Unit, University Hospital Necker-Enfants-Malades (APHP), Paris, France
Search for more papers by this authorMartin Castelle
Hematology-Immunology Department, University Hospital Necker Enfants Malades (APHP), Paris, France
Search for more papers by this authorAndré Baruchel
Pediatric Hematology-Immunology Department, University Hospital Robert-Debre (APHP), Paris, France
University of Paris, UFR Paris-Nord, Paris, France
Search for more papers by this authorCorresponding Author
Aphaia Roussel
Pediatric Hematology-Immunology Department, University Hospital Robert-Debre (APHP), Paris, France
Correspondence
Aphaia Roussel, Pediatric Hematology-Immunology Department, University Hospital Robert Debré (APHP), 48 Bd Sérurier, Cedex 19, 75935 Paris, France.
Email: [email protected]
Search for more papers by this authorDavid Germanaud
Pediatric Neurology Department, University Hospital Robert-Debre (APHP), Paris, France
Search for more papers by this authorYassine Bouchoucha
Pediatric Hematology-Immunology Department, University Hospital Robert-Debre (APHP), Paris, France
Search for more papers by this authorNaïm Ouldali
General Pediatric Department and Infectious Diseases, University Hospital Robert-Debre (APHP), Paris, France
Search for more papers by this authorMeryl Vedrenne-Cloquet
Pediatric Intensive Care Unit, University Hospital Necker-Enfants-Malades (APHP), Paris, France
Search for more papers by this authorMartin Castelle
Hematology-Immunology Department, University Hospital Necker Enfants Malades (APHP), Paris, France
Search for more papers by this authorAndré Baruchel
Pediatric Hematology-Immunology Department, University Hospital Robert-Debre (APHP), Paris, France
University of Paris, UFR Paris-Nord, Paris, France
Search for more papers by this authorCONFLICT OF INTEREST
The other authors declare that there is no conflict of interest.
Supporting Information
| Filename | Description |
|---|---|
| pbc28707-sup-0001-figureS1.png68.9 KB | Supplementary Figure: Timeline of the medical events preceding and following infection with SARS-CoV-2 |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720.
- 2Su L, Ma X, Yu H, et al. The different clinical characteristics of corona virus disease cases between children and their families in China: the character of children with COVID-19. Emerg Microbes Infect. 2020; 9(1): 707-713.
- 3Liu W, Zhang Q, Chen J, et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020; 382(14): 1370-1371.
- 4Sun D, Li H, Lu X-X, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study. World J Pediatr. 2020; 16: 251-259.
- 5Marc D, Dominique JF, Élodie B, et al. Human coronavirus: respiratory pathogens revisited as infectious neuroinvasive, neurotropic, and neurovirulent agents. In: SK Singh, D Ruzek, eds. Neuroviral Infections: RNA Viruses and Retroviruses. Boca Raton, FL: CRC Press; 2013: 93-122. https://www.researchgate.net/publication/243457712_Human_coronavirus_respiratory_pathogens_revisited_as_infectious_neuroinvasive_neurotropic_and_neurovirulent_agents.
- 6Christy A. COVID-19: a review for the pediatric neurologist [published online ahead of print, 2020 July 13]. J Child Neurol. 2020.https://doi.org/10.1177/0883073820939387
- 7Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77: 1-9.
- 8Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020; 382: 2574-2576.
- 9Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020; 19: 383-384.
- 10Abdel-Mannan O, Eyre M, Löbel U, et al. Neurologic and radiographic findings associated with COVID-19 infection in children [published online ahead of print, 2020 July 1]. JAMA Neurol. 2020:e202687.
